US 6462067
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
expired A61KA61K31/00A61K31/33
Quick answer
US patent 6462067 (Treatment and prevention of reactive oxygen metabolite-mediated cellular damage) held by Maxim Pharmaceuticals, Inc. expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Maxim Pharmaceuticals, Inc.
- Grant date
- Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/00, A61K31/33, A61K31/4045, A61K31/417